INNOVADERM CRO IS NOW INDERO.

Regulatory & Clinical Development Consulting

End-to-end regulatory, drug and clinical development consulting that supports more efficient outcomes.

Trusted By

Aldena Therapeutics

End-to-End Regulatory & Clinical Development Services

Looking to break into another country’s market? Need support with your regulatory submissions or regulatory guidance? Accelerate your drug development project and reclaim valuable time by working with Indero.

Regulatory Drug Submissions

  • Pre-IND (Includes CMC and Pharmacology/Toxicology)​
  • Investigational New Drug (IND)
  • Investigational Medicinal Product Dossiers (IMPD)
  • Clinical Trial Applications (CTA)
  • Expedited Suspected Unexpected Serious Adverse Reaction (SUSAR) to regulatory authorities and Central Institutional Review Board (cIRB)
  • End of phase II (EOP2)
  • New Drug Application (NDA)
  • Marketing Authorization Applications (MAA)
  • Abbreviated New Drug Applications (ANDAs)
  • Clinical Trials Information System (CTIS) submission
  • Eudravigilance Medicinal Product dictionary drug product registration for CTIS

Regulatory Device Submissions

  • Investigational Device Exemption (IDE)
  • 510(k)
  • Premarket Approval (PMA)

 

Medical & Scientific Writing

  • Clinical protocols
  • Synopsis development
  • Report on Previous Investigations ROPI
  • Clinical sections of regulatory submissions
  • Clinical Study Reports (CSR)
  • Serious Adverse Event (SAE) narratives
  • Investigator’s Brochures (IB)
  • Pediatric Study Plan (PSP) and Pediatric Investigation Plan (PIP)
Thibaud Portal headshot
Andrea Epperly head shot

Thibaud Portal

Founder and CEO
Alys Pharmaceuticals

Andrea Epperly

Global Head of Project Management
Alys Pharmaceuticals

Thibaud Portal headshot

Thibaud Portal

Founder and CEO
Alys Pharmaceuticals

Andrea Epperly head shot

Andrea Epperly

Global Head of Project Management
Alys Pharmaceuticals

“Congratulations to the team for a very positive pre-IND meeting outcome! Your dedication, and well-executed plans have laid a strong foundation for our program. This success is a significant trust-building milestone with the agency. Thank you for your outstanding work!”

Scientific Support 

  • Clinical Development Plan (CDP)
  • Clinical development strategy
  • Study design recommendations
  • Endpoints and inclusion and exclusion criteria advice
  • Alignment with regulations
  • Literature review

 

Clinical Pre-Feasability 

  • Meetings with KOLs
  • Pre-feasibility report writing
  • Support in literature review

Meeting with Regulatory Agencies

  • Support agency meeting preparation
  • Writing narratives for agency questions
  • Optimal communications with FDA, EMA and other global agencies
  • Sponsor representation
  • Briefing documents support for every global regulatory meeting, anywhere in the world

Regulatory Consultation

  • EU Clinical Trial Regulation No 536/2014 consultancy
  • EU CTIS consultancy
  • Regulatory strategy consultancy
  • Preclinical toxicology consultancy
  • Preclinical pharmacology consultancy
  • CMC consultancy
Top view of medical office staff meeting at a table

Where Regulatory Rigor Meets Scientific Insight​

Study Design

From adaptive design, MOA, SAD-MAD-POC, MUsT, MUSE, Intraindividual, disease characterization, we have mastered the art of scientific innovation while strictly complying with regulatory requirements.

Endpoint Selection

Aligning with FDA expectations, championing patient-centric values, and crafting feasible study designs with uncompromised data quality.

Biomarker Use

We elevate translational research strategies, daring to venture beyond traditional sampling techniques. Our dedicated exploration of biomarkers is conducted with the utmost level of sensitivity.

Partner with Indero’s Regulatory & Cilnical Development Team

Indero provides​ unparalleled regulatory, drug and clinical development consulting services​ to support your success. Tell us about your clinical trial needs.

Successfully Supported Pre-IND Submission & FDA Meeting for Vitiligo Asset

The client sought support for their pre-IND submission and development program. Our goal was to contribute to the clinical section of the pre-IND submission package and prepare clinical questions for their Vitiligo asset.

Services

Pre-IND Submission Development

  • Clinical Section Development: Assisted in preparing the required pre-IND submission package, detailing their planned clinical activities.
  • Study Synopsis: Developed the study synopsis and plan for their first clinical study, ensuring alignment with regulatory requirements.

FDA Question Development

  • Question Formulation: Created a set of questions for the FDA, including rationale and study design suggestions, based on our extensive experience.
  • Literature Analysis: Conducted literature reviews to support the proposed study designs and questions.

Meeting Preparation

  • Scenario Planning: Prepared narratives for various potential FDA scenarios, helping the client anticipate and prepare for different outcomes.
  • FDA Meeting Representative: Actively participated in the FDA video conference to provide real-time answers to any questions. Developed a supportive document to address the FDA’s clinical questions, incorporating literature research and client discussions.

Outcome

FDA Meeting

  • The client successfully engaged with the FDA in a virtual meeting.
  • Despite high concerns, the FDA agreed with their proposed plan by the end of the meeting.

Regulatory & Clinical Development Consulting that Accelerates Studies

Scientific discipline. Operational efficiency. Clinical development expertise. Our end-to-end regulatory and clinical development consulting services provide the rigorous foundation, quality data and expertise dermatology & rheumatology studies need to ensure effective execution and on-time delivery.

“Great experience working with the Indero team for our pre-IND and IND preparation. Knowledgeable, collaborative, and truly patient-oriented. Working together as a single team—highly recommend!”

Claire Blanchard head shot

Carine Blanchard

Chief Scientific Officer

Aldena Therapeutics

Aldena Therapeutics
circle

Wherever You’re Going,
We’re all in.

Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.

Is Now

We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Additionally, our Clinical Research Unit (CRU) will keep the name Innovaderm and will continue to conduct dermatology studies.

Site Selection & Management

Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.

Hands, tablet and contact us with healthcare marketing or advertising on a website in the medical industry.

Patient Recruitment

Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.